Paul Menard-Katcher, MD
Internal Medicine · Aurora, CONPI 1104980291
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $31,106 of the $31,922 with a category attached, or 97.4%. Evoendo, Inc accounts for 97.4% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2023 at $31,173 and has fallen 99.3% since, to $208 in 2025. Among internal medicine clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 13 payments — averaging $2455.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Evoendo, Inc$31K
- Olympus America Inc.$311
- Regeneron Healthcare Solutions, Inc.$183
- Boston Scientific$127
- Conmed Corporation$107
- Medtronic$88
Across 54 payments — averaging $3196.05 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$154K
- Ironwood Pharmaceuticals, Inc$19K
What the payments were for
- Consulting fees$31,10697%
- Food & beverage$8153%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Evoendo, Inc | 1 | $31,106 |
| Olympus America Inc. | 4 | $311 |
| Regeneron Healthcare Solutions, Inc. | 2 | $183 |
| Boston Scientific | 2 | $127 |
| Conmed Corporation | 1 | $107 |
| Medtronic | 3 | $88 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EVIS EXERA III BRONCHOVIDEOSCOPE$246
- DUPIXENT$116
- CONMED EUS$107
- CONMED HEMOSTASIS$107
How this compares
$31,922 in reported general payments places this provider in the 95th percentile of 1,430 internal medicine providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XifaxanRifaximin | 13 | $29,555 |
| MotegrityPrucalopride Succinate | 11 | $14,946 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 51 | $3,311 |
| Omeprazole | 53 | $1,723 |
| Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl | 74 | $1,249 |
| Bethanechol Chloride | 14 | $818 |
| Pantoprazole Sodium | 27 | $405 |
| Fluconazole | 15 | $295 |
| Famotidine | 26 | $251 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Aurora
- Kristine KuhnAurora$61K
- Cherry DelosreyesAurora$15K
- Shabana JiwaniAurora$10K
- Shahzaib NabiAurora$10K
- Mauricio WaintrubAurora$9K
- Javier WaksmanAurora$7K
- Kelsey FlintAurora$6K
- Gilad GordonBoulder$476K
- Kathryn PolovitzParker$403K
- Monica GrafalsAvon$401K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.